Outlook Therapeutics (OTLK) Net Margin (QoQ) (2015 - 2025)
Outlook Therapeutics (OTLK) Net Margin (QoQ) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
| Date | Value |
|---|
| Sep 30, 2025 |
1.58 Mn |
| Sep 30, 2019 |
61,246.00 |
| Jun 30, 2019 |
97,321.00 |
| Mar 31, 2019 |
-83,432.00 |
| Dec 31, 2018 |
71,220.00 |
| Sep 30, 2018 |
-46,188.00 |
| Jun 30, 2018 |
-6,818.00 |
| Mar 31, 2018 |
118,774.00 |
| Dec 31, 2017 |
-203,632.00 |
| Sep 30, 2017 |
149,856.00 |
| Jun 30, 2017 |
89,550.00 |
| Mar 31, 2017 |
364,600.00 |
| Dec 31, 2016 |
-416,481.00 |
| Sep 30, 2016 |
396,580.00 |
| Jun 30, 2016 |
-564,157.00 |
| Mar 31, 2016 |
132,989.00 |
| Dec 31, 2015 |
190,294.00 |
| Sep 30, 2015 |
-273,239.00 |
| Jun 30, 2015 |
208,777.00 |
